BRIEF

on DIAGNOSTIC MEDICAL (EPA:ALDMS)

Diagnostic Medical Reports Half-Year Liquidity Contract Status

Stock price chart of DIAGNOSTIC MEDICAL (EPA:ALDMS) showing fluctuations.

Diagnostic Medical Systems (DMS), listed on Euronext Growth Paris, reported the half-year results of its liquidity contract with NATIXIS ODDO BHF as of December 31, 2025. The liquidity account held 110,630 shares and €102,349 at the end of the period. Initially, it had 150,000 shares and €50,000 upon setup on May 7, 2025.

Between July 1 and December 31, 2025, the liquidity account executed 1,155 purchase transactions and 1,153 sale transactions. The traded volumes amounted to 248,152 shares worth €330,540 for purchases, and 253,627 shares worth €342,117 for sales.

DMS announced upcoming financial results: the 2025 annual revenue on January 19, 2026, the annual results on April 14, 2026, and the Q1 2026 revenue on April 21, 2026, post market close. Further details are available on the DMS website.

R. P.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DIAGNOSTIC MEDICAL news